Literature DB >> 1712647

Selective expression of two homeobox genes in CD34-positive cells from human bone marrow.

Y Deguchi1, J H Kehrl.   

Abstract

Proteins coded by homeobox-containing genes are sequence-specific DNA-binding proteins that have been implicated in the control of gene expression both in developing as well as in adult tissues. Two recently characterized human homeobox genes, HB24 and HB9, were found to be highly expressed in bone marrow cells enriched for CD34-positive cells, present at low levels in unfractionated bone marrow cells, and essentially undetectable in bone marrow cells depleted of CD34 cells. Treatment of CD34-enriched cells with recombinant interleukin-3 (IL-3) and granulocyte macrophage-colony-stimulating factor for 24 hours increased expression of HB24 threefold and HB9 fourfold. Based on studies with actinomycin D, the HB24 and HB9 transcripts in human CD34-positive cells have short half-lives, estimated to be 30 to 45 minutes. Downregulation of HB24 and HB9 expression was found following the treatment of in vitro cultures of CD34-positive cells with IL-3. Thus, the differentiation of CD34-positive cells along a specific cell lineage likely requires downregulation of both HB24 and HB9.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712647

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells.

Authors:  M R Crompton; T J Bartlett; A D MacGregor; G Manfioletti; E Buratti; V Giancotti; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Homeobox gene HLX1 expression is decreased in idiopathic human fetal growth restriction.

Authors:  Padma Murthi; Vicki Doherty; Joanne Said; Susan Donath; Shaun P Brennecke; Bill Kalionis
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Authors:  G Sauvageau; P M Lansdorp; C J Eaves; D E Hogge; W H Dragowska; D S Reid; C Largman; H J Lawrence; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

4.  H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia.

Authors:  Masahiro Kawahara; Ashley Pandolfi; Boris Bartholdy; Laura Barreyro; Britta Will; Michael Roth; Ujunwa C Okoye-Okafor; Tihomira I Todorova; Maria E Figueroa; Ari Melnick; Constantine S Mitsiades; Ulrich Steidl
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

5.  The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells.

Authors:  Julia Testori; Bernhard Schweighofer; Iris Helfrich; Caterina Sturtzel; Karoline Lipnik; Sabine Gesierich; Patrick Nasarre; Renate Hofer-Warbinek; Martin Bilban; Hellmut G Augustin; Erhard Hofer
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

6.  HEX: a novel homeobox gene expressed during haematopoiesis and conserved between mouse and human.

Authors:  F K Bedford; A Ashworth; T Enver; L M Wiedemann
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

7.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

8.  Endo-MitoEGFP mice: a novel transgenic mouse with fluorescently marked mitochondria in microvascular endothelial cells.

Authors:  Sarah Pickles; Maxime Cadieux-Dion; Jorge I Alvarez; Marc-Andre Lécuyer; Sarah L Peyrard; Laurie Destroismaisons; Lydia St-Onge; Simone Terouz; Patrick Cossette; Alexandre Prat; Christine Vande Velde
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

Review 9.  Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Authors:  Sabrina Tosi; Yasser Mostafa Kamel; Temitayo Owoka; Concetta Federico; Tony H Truong; Salvatore Saccone
Journal:  Biomark Res       Date:  2015-10-05

10.  A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways.

Authors:  Indre Piragyte; Thomas Clapes; Aikaterini Polyzou; Ramon I Klein Geltink; Stylianos Lefkopoulos; Na Yin; Pierre Cauchy; Jonathan D Curtis; Lhéanna Klaeylé; Xavier Langa; Cora C A Beckmann; Marcin W Wlodarski; Patrick Müller; Dominic Van Essen; Angelika Rambold; Friedrich G Kapp; Marina Mione; Joerg M Buescher; Erika L Pearce; Alexander Polyzos; Eirini Trompouki
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.